The patient perspective in the era of personalized medicine: What about scanxiety?

Frequency of scanning has accelerated in the era of personalized medicine and is related, but not restricted, to the exploding number of clinical trials for new cancer treatments. Particularly in drug trials, but also in clinical practice, patients are followed up by scans frequently, which may vary...

Descripción completa

Detalles Bibliográficos
Autores principales: Custers, José A. E., Davis, Lucy, Messiou, Christina, Prins, Judith B., van der Graaf, Winette T. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085965/
https://www.ncbi.nlm.nih.gov/pubmed/33837668
http://dx.doi.org/10.1002/cam4.3889
_version_ 1783686435429154816
author Custers, José A. E.
Davis, Lucy
Messiou, Christina
Prins, Judith B.
van der Graaf, Winette T. A.
author_facet Custers, José A. E.
Davis, Lucy
Messiou, Christina
Prins, Judith B.
van der Graaf, Winette T. A.
author_sort Custers, José A. E.
collection PubMed
description Frequency of scanning has accelerated in the era of personalized medicine and is related, but not restricted, to the exploding number of clinical trials for new cancer treatments. Particularly in drug trials, but also in clinical practice, patients are followed up by scans frequently, which may vary from every 6 to 12 weeks until progression. The authors aimed to raise awareness for this underreported but widely present “Sword of Damocles” scan‐related issue also referred to as ‘scanxiety.’ [Image: see text]
format Online
Article
Text
id pubmed-8085965
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80859652021-05-07 The patient perspective in the era of personalized medicine: What about scanxiety? Custers, José A. E. Davis, Lucy Messiou, Christina Prins, Judith B. van der Graaf, Winette T. A. Cancer Med Clinical Cancer Research Frequency of scanning has accelerated in the era of personalized medicine and is related, but not restricted, to the exploding number of clinical trials for new cancer treatments. Particularly in drug trials, but also in clinical practice, patients are followed up by scans frequently, which may vary from every 6 to 12 weeks until progression. The authors aimed to raise awareness for this underreported but widely present “Sword of Damocles” scan‐related issue also referred to as ‘scanxiety.’ [Image: see text] John Wiley and Sons Inc. 2021-04-09 /pmc/articles/PMC8085965/ /pubmed/33837668 http://dx.doi.org/10.1002/cam4.3889 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Custers, José A. E.
Davis, Lucy
Messiou, Christina
Prins, Judith B.
van der Graaf, Winette T. A.
The patient perspective in the era of personalized medicine: What about scanxiety?
title The patient perspective in the era of personalized medicine: What about scanxiety?
title_full The patient perspective in the era of personalized medicine: What about scanxiety?
title_fullStr The patient perspective in the era of personalized medicine: What about scanxiety?
title_full_unstemmed The patient perspective in the era of personalized medicine: What about scanxiety?
title_short The patient perspective in the era of personalized medicine: What about scanxiety?
title_sort patient perspective in the era of personalized medicine: what about scanxiety?
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085965/
https://www.ncbi.nlm.nih.gov/pubmed/33837668
http://dx.doi.org/10.1002/cam4.3889
work_keys_str_mv AT custersjoseae thepatientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT davislucy thepatientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT messiouchristina thepatientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT prinsjudithb thepatientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT vandergraafwinetteta thepatientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT custersjoseae patientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT davislucy patientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT messiouchristina patientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT prinsjudithb patientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety
AT vandergraafwinetteta patientperspectiveintheeraofpersonalizedmedicinewhataboutscanxiety

Ejemplares similares